| Type 2 Diabetes Mellitus |
| Improved glycemic control when diet and exercise are insufficient |
| Dual mechanism therapy (insulin secretion + insulin sensitivity) |
Tablet
This fixed-dose combination provides dual benefits in type 2 diabetes management. Glipizide stimulates insulin secretion, while Metformin reduces hepatic glucose production and improves insulin sensitivity.
| Speciality | Endocrinology | Diabetology | General Medicine |
|---|---|
| Tags | Sulfonylurea | Biguanide | Type 2 Diabetes | Blood Sugar Control |
| Strength |
|
| Packing Size |
|
All product details on this website are for reference and informational purposes only and
are not directed at patients or consumers.
As a contract manufacturer,
DM Pharma Pvt Ltd is not responsible for the marketing or end use of these products and disclaims all
liability arising from reliance on this information.
Please consult a healthcare professional before
using any medicinal product.